Floatz logo

7 assets in Hodgkin'S Lymphoma, Lymphocytic Depletion

Therapeutic assets addressing Hodgkin'S Lymphoma, Lymphocytic Depletion, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Adriamycin
Hodgkin'S Lymphoma, Lymphocytic Depletion
National Cancer Institute (NCI)P3BB (69)
Nivestim
Hodgkin'S Lymphoma, Lymphocytic Depletion
National Cancer Institute (NCI)P3BB (69)
Dacarbazine
Hodgkin'S Lymphoma, Lymphocytic Depletion
National Cancer Institute (NCI)P3BB (66)
Vinblastine
Hodgkin'S Lymphoma, Lymphocytic Depletion
National Cancer Institute (NCI)P3BB (66)
Brentuximab Vedotin
Hodgkin'S Lymphoma, Lymphocytic Depletion
National Cancer Institute (NCI)P3B (60)
Nivolumab
Hodgkin'S Lymphoma, Lymphocytic Depletion
National Cancer Institute (NCI)P3B (60)
Pegfilgrastim
Hodgkin'S Lymphoma, Lymphocytic Depletion
National Cancer Institute (NCI)P3B (60)